Search
DeepMed has successfully completed a Pre-A funding round, securing tens of millions of yuan, with Wondfo Valley as the lead investor. The company specializes in the realm of microsurgery robots, showcasing its flagship product, FUNZAR, which boasts high-precision robotic arms and an advanced 3D vision system. FUNZAR has triumphantly navigated through multiple clinical trials, validating its efficacy and setting the stage for its market debut. Poised to spearhead the intelligence of microscopic surgery across all domains, FUNZAR is poised to redefine the benchmarks of microsurgery. The DeepMed team, renowned for its technological prowess and robust patent portfolio, has garnered significant praise from investors and industry authorities alike.
-
C114 Communication Network -
Communication Home
